Dr. Owonikoko on Talazoparib in HRRD-Positive Stage IV Squamous Cell Lung Cancer

Cancer Network spoke with Taofeek Kunle Owonikoko, MD, PhD, of  Emory University, about talazoparib for patients with HRRD-positive stage IV squamous cell lung cancer.

Source: CancerNetwork - June 11, 2019 Category: Cancer & Oncology Authors: Taofeek K. Owonikoko, MD, PhD Source Type: news